BAZIMTO
DEAD

Serial Number

79286775

Owner

NOVARTIS AG

Filing Date

Apr 23, 2020

Add to watchlist:

No watchlists yet
View on USPTO

BAZIMTO Trademark

Serial Number: 79286775

BAZIMTO is a trademark filed by NOVARTIS AG on April 23, 2020. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

NOVARTIS AG (7,172 trademarks)

CH-4002
BASEL , CH

Entity Type: 03

SANDOZ AG (211 trademarks)

VIADUKTSTRASSE 3
BASEL 4051 , CH

Entity Type: 03

Trademark Details

Filing Date

April 23, 2020

Registration Date

Not Registered

Goods & Services

antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Filing History

CHANGE OF OWNER RECEIVED FROM IB
Jan 19, 2024 CHLD
FINAL DECISION TRANSACTION PROCESSED BY IB
Mar 21, 2022 FINT
FINAL DISPOSITION NOTICE SENT TO IB
Mar 1, 2022 FICS
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Mar 1, 2022 FICR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Nov 28, 2021 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Nov 10, 2021 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Nov 10, 2021 OPNR
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Mar 1, 2021 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Mar 1, 2021 ABN2
ATTORNEY REVIEW COMPLETED
Feb 3, 2021 ATRV
LIMITATION FROM THE IB - REQUEST EXAM REVIEW
Jan 23, 2021 LIME
LIMITATION OF GOODS RECEIVED FROM IB
Nov 13, 2020 LIMG
REFUSAL PROCESSED BY IB
Sep 5, 2020 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Aug 18, 2020 RFCS
REFUSAL PROCESSED BY MPU
Aug 18, 2020 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jul 8, 2020 RFCR
NON-FINAL ACTION WRITTEN
Jul 7, 2020 CNRT
ASSIGNED TO EXAMINER
Jul 6, 2020 DOCK
APPLICATION FILING RECEIPT MAILED
Jun 20, 2020 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 16, 2020 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Jun 12, 2020 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jun 4, 2020 REPR